Skip to main content

Table 1 Clinical characteristics at baseline

From: Usefulness of echocardiographic myocardial work in evaluating the microvascular perfusion in STEMI patients after revascularization

 

Normal MVP group (n = 64)

Abnormal MVP group (n = 96)

P

Age (years)

60 ± 11

58 ± 14

0.275

Male, n (%)

48 (75.0)

73 (76.0)

0.880

BMI (kg/m2)

26.1 ± 3.6

25.2 ± 3.8

0.155

Smoker, n (%)

41 (64.1)

54 (56.3)

0.324

Hypertension, n (%)

46 (71.9)

58 (60.4)

0.137

Diabetes, n (%)

25 (39.1)

33 (34.4)

0.546

Chronic kidney disease, n (%)

11 (17.2)

5 (5.2)

0.013

Previous myocardial infarction, n (%)

4 (6.3)

9 (9.4)

0.478

SBP at admission (mmHg)

125 ± 20

115 ± 20

0.016

DBP at admission (mmHg)

78 ± 15

73 ± 13

0.071

Heart rate at admission (bpm)

79 ± 14

81 ± 20

0.627

Killip classification I, n (%)

59 (92.2)

75 (78.1)

0.018

Symptom onset to balloon time (h)

6.7 (3.7–46.0)

6.2 (3.7–9.9)

0.122

Maximum troponin I (ng/ml)

27.9 (12.7–80.0)

75.1 (26.4–124.0)

0.003

CRP (mg/L)

2.7 (0.5–12.2)

8.2 (0.7–39.2)

0.082

BNP (pg/ml)

186.5 (59.3–380.0)

285.0 (91.0–635.0)

0.058

Serum creatinine (μmol/L)

78.0 (66.0–103.5)

81.0 (63.0–95.0)

0.600

Angiographic data

 Three-vessel disease, n (%)

38 (59.4)

40 (41.7)

0.028

 Final TIMI flow ≤ 2, n (%)

5 (7.9)

23 (25.0)

0.007

 LAD STEMI, n (%)

25 (39.1)

67 (69.8)

0.000

 RCA STEMI, n (%)

33 (51.6)

18 (18.8)

0.000

 LCx STEMI, n (%)

6 (9.4)

11 (11.5)

0.675

  1. BMI body mass index, BNP brain natriuretic peptide, CRP C-reactive protein, DBP diastolic blood pressure, LAD left anterior descending, LCx left circumflex artery, MVP microvascular perfusion, RCA right coronary artery, SBP systolic blood pressure, STEMI ST-segment elevation myocardial infarction, TIMI thrombolysis in myocardial infarction